federal agency

Sheriff Robert Luna has asked the National Institute of Corrections to examine conditions and practices at Los Angeles County jails, a request made after 10 inmates died in jail custody in less than three months.

The request comes amid growing concern over conditions inside county lockups. In September, California Atty. Gen. Rob Bonta sued the Sheriff’s Department over what he called “unsafe and unconstitutional conditions at county jails.”

Luna has also faced questions from the Sheriff Civilian Oversight Commission over health conditions, health access, drug use, and other factors that have led to in-custody deaths.

Now, the Sheriff’s Department is asking the National Institute of Corrections to conduct a comprehensive review of county jails in an effort to reduce the number of deaths, Luna told The Times.

“I want someone to come in and review from top to bottom,” Luna said.

Specifics on when the review would begin, and what it would entail, have not yet been set, but Luna said the aim is to get an outside, “unbiased view.”

Officials with the National Institute of Corrections referred questions to the federal Bureau of Prisons, its parent agency, which did not respond to a request for comment.

The National Institute of Corrections provides state, local and federal resources and guidance.

The agency, according to its site, provides “on site technical assistance” to jail administrators, and also helps to identify “gaps in policy and practice.”

The review, Luna said, would entail “everything we’re doing from policy, procedure, facilities, to make sure we’re not missing anything,” Luna said.

Inmate deaths have raised concerns among top sheriff officials and agencies charged with overseeing sheriff operations. The department saw 46 in-custody deaths in 2025, a steep increase from the 32 reported in 2024.

In-custody deaths are reviewed by the Office of Inspector General and the U.S. Department of Justice.

Bonta’s lawsuit against the Sheriff’s Department, filed in September 2025, alleged inmates were being “forced to live in filthy cells with broken and overflowing toilets, infestations of rats and roaches, and no clean water for drinking or bathing.”

In a statement, Bonta’s office alleged that a lack of access to healthcare in the jails, and conditions inside, contributed to a “shocking rate of preventable in-custody deaths, such as suicides.”

In a previous interview, Luna referred to the spate of death at the start of the year as a “kick in the groin.”

Efforts to reduce deaths are challenging partly because the inmate population inside the jails has been increasingly older, and ill, Luna said, with many of them suffering from drug addiction or long-term conditions.

About 82% of those in custody disclosed at least one medical or mental health issue when booked, officials said.

According to department data, half of the 46 inmate deaths recorded in 2025 were listed as natural. Autopsy results to determine the causes of death are still pending in this year’s cases.

Luna has pointed to changes that have already been made as efforts to improve conditions, including deploying body-worn cameras at the Inmate Reception Center, Men’s Central Jail and Twin Towers Correctional Facility.

The department has also opened a remodeled mental health assessment area at the Inmate Reception Center, the primary intake and release point for county inmates near Men’s Central Jail.

The Trump administration on Friday moved to roll back Biden-era limits on emissions of ethylene oxide, a cancer-causing chemical often used in the sterilization of medical devices.

The Environmental Protection Agency said repealing the rules, which fall under the National Emission Standards for Hazardous Air Pollutants, would “safeguard the supply of essential medical equipment” — saving approximately $630 million for companies over 20 years. California is home to about a dozen such facilities.

The government said the emissions are part and parcel of protecting people from “lethal or significantly debilitating infections that would result without properly sterilized medical equipment.”

“The Trump EPA is committed to ensuring life-saving medical devices remain available for the critical care of America’s children, elderly, and all patients without unnecessary exposure to communities,” EPA Administrator Lee Zeldin said in a statement.

An estimated 50% of sterile medical devices in the U.S. are treated with ethylene oxide, or EtO, particularly those that can’t be cleaned using steam or radiation. The colorless gas is also used to make chemicals found in products such as antifreeze, detergents, plastics and adhesives.

But EtO poses health risks. Short-term exposure by inhalation can cause headaches, dizziness, nausea, fatigue respiratory irritation and other adverse health effects, according to the federal Agency for Toxic Substances and Disease Registry.

Longer-term exposure increases the risk of cancers of the white blood cells, such as non-Hodgkin’s lymphoma, as well as breast cancer. A now-deleted page from the EPA’s website stated, “EtO is a human carcinogen. It causes cancer in humans.”

Friday’s proposal specifically targets updated rules for EtO emissions that were passed by the Biden administration in 2024 following pressure from environmental justice groups, particularly those in Louisiana’s heavily industrialized “Cancer Alley.” The change sought to reduce the amount of EtO released from commercial sterilizers by 90% and lessen the hazards for nearby communities.

The tighter rules were in part based on EPA’s own scientific study that found it to be 60 times more carcinogenic than previously thought, which the agency now says should be reassessed.

If finalized, the plan would give facilities the choice between installing continuous real-time monitoring systems for EtO emissions or complying with modified pollution control requirements at facilities that emit more than 10 tons a year, the EPA said.

The proposal follows other moves by the Trump administration to rescind regulations that it says are burdensome and costly for industries, such as those governing emissions from coal power plants. Last month, the EPA repealed the endangerment finding, which affirmed the dangers of greenhouse gas emissions and underpinned the agency’s ability to regulate those emissions from vehicles.

The action around ethylene oxide would affect about 90 commercial sterilization facilities owned and operated by approximately 50 companies. Three California companies applied for and received presidential exemptions for their EtO emissions in July.

The Sterigenics facility, center, in Vernon is pictured in 2022.

(Myung J. Chun / Los Angeles Times)

They are located in Ontario and Vernon and operated by the company Sterigenics, which provides industrial sterilization technology for medical devices and other commercial products.

In January, a coalition of environmental and community groups challenged the EtO exemptions in federal court. The lawsuit from the Southern Environmental Law Center and the Natural Resources Defense Council argues that technology exists for facilities to comply with the tighter Biden-era standards without raising costs, and many facilities are already using it.

“EPA’s 2024 rule was an important and overdue step to reduce toxic ethylene oxide pollution and protect communities,” said Irena Como, senior attorney at the Southern Environmental Law Center, in a statement Friday. “Repealing this rule that is proven to significantly lower pollution exposure and cancer risks will subject even more people who work, live, and send their children to schools located near these facilities to harm that is entirely preventable.”

Sterilization and chemical industry groups support the plan.

“The EPA rule concerning ethylene oxide use in commercial sterilizers threatens to severely restrict access to vital medical products nationwide,” the American Chemistry Council said in a statement. “We commend the EPA for their commitment to reevaluating these policies.”

The EPA will hold a 45-day comment period about the proposal after it is published in the federal register. A final decision is expected sometime this year.

President Trump on Friday directed federal agencies to stop using technology from San Francisco artificial intelligence company Anthropic, escalating a high-profile clash between the AI startup and the Pentagon over safety.

In a Friday post on the social media site Truth Social, Trump described the company as “radical left” and “woke.”

“We don’t need it, we don’t want it, and will not do business with them again!” Trump said.

The president’s harsh words mark a major escalation in the ongoing battle between some in the Trump administration and several technology companies over the use of artificial intelligence in defense tech.

Anthropic has been sparring with the Pentagon, which had threatened to end its $200-million contract with the company on Friday if it didn’t loosen restrictions on its AI model so it could be used for more military purposes. Anthropic had been asking for more guarantees that its tech wouldn’t be used for surveillance of Americans or autonomous weapons.

The tussle could hobble Anthropic’s business with the government. The Trump administration said the company was added to a sweeping national security blacklist, ordering federal agencies to immediately discontinue use of its products and barring any government contractors from maintaining ties with it.

Defense Secretary Pete Hegseth, who met with Anthropic’s Chief Executive Dario Amodei this week, criticized the tech company after Trump’s Truth Social post.

“Anthropic delivered a master class in arrogance and betrayal as well as a textbook case of how not to do business with the United States Government or the Pentagon,” he wrote Friday on social media site X.

Anthropic didn’t immediately respond to a request for comment.

Anthropic announced a two-year agreement with the Department of Defense in July to “prototype frontier AI capabilities that advance U.S. national security.”

The company has an AI chatbot called Claude, but it also built a custom AI system for U.S. national security customers.

On Thursday, Amodei signaled the company wouldn’t cave to the Department of Defense’s demands to loosen safety restrictions on its AI models.

The government has emphasized in negotiations that it wants to use Anthropic’s technology only for legal purposes, and the safeguards Anthropic wants are already covered by the law.

Still, Amodei was worried about Washington’s commitment.

“We have never raised objections to particular military operations nor attempted to limit use of our technology in an ad hoc manner,” he said in a blog post. “However, in a narrow set of cases, we believe AI can undermine, rather than defend, democratic values.”

Tech workers have backed Anthropic’s stance.

Unions and worker groups representing 700,000 employees at Amazon, Google and Microsoft said this week in a joint statement that they’re urging their employers to reject these demands as well if they have additional contracts with the Pentagon.

“Our employers are already complicit in providing their technologies to power mass atrocities and war crimes; capitulating to the Pentagon’s intimidation will only further implicate our labor in violence and repression,” the statement said.

Anthropic’s standoff with the U.S. government could benefit its competitors, such as Elon Musk’s xAI or OpenAI.

Sam Altman, chief executive of OpenAI, the company behind ChatGPT and one of Anthropic’s biggest competitors, told CNBC in an interview that he trusts Anthropic.

“I think they really do care about safety, and I’ve been happy that they’ve been supporting our war fighters,” he said. “I’m not sure where this is going to go.”

Anthropic has distinguished itself from its rivals by touting its concern about AI safety.

The company, valued at roughly $380 billion, is legally required to balance making money with advancing the company’s public benefit of “responsible development and maintenance of advanced AI for the long-term benefit of humanity.”

Developers, businesses, government agencies and other organizations use Anthropic’s tools. Its chatbot can generate code, write text and perform other tasks. Anthropic also offers an AI assistant for consumers and makes money from paid subscriptions as well as contracts. Unlike OpenAI, which is testing ads in ChatGPT, Anthropic has pledged not to show ads in its chatbot Claude.

The company has roughly 2,000 employees and has revenue equivalent to about $14 billion a year.